Efgartigimod concentrate for solution for infusion 20 mg/mL

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
11	重症筋無力症	1

11. 重症筋無力症

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04980495 (ClinicalTrials.gov)	December 16, 2021	19/7/2021	An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimo ...	A Phase 3b, Randomized, Open-label, Parallel-Group Study to Evaluate Different Dosing Regimens of In ...	Generalized Myasthenia Gravis	Biological: Efgartigimod concentrate for solution for infusion 20 mg/mL	argenx	NULL	Recruiting	18 Years	N/A	All	72	Phase 3	United States;Austria;Belgium;Canada;France;Georgia;Germany;Italy;Netherlands;Poland;Spain

First Previous1Next Last